Premium
This is an archive article published on June 10, 2014

Healthy seniors tested in bid to block Alzheimer’s

Scientists are beginning a major study to see if an experimental drug can protect healthy seniors from the risk of Alzheimer's.

Researchers expect to screen thousands of volunteers ages 65 to 85, hunting those whose brain scans show they have a sticky build-up believed to play a key role in development of Alzheimer's.  Source: Thinkstock Images Researchers expect to screen thousands of volunteers ages 65 to 85, hunting those whose brain scans show they have a sticky build-up believed to play a key role in development of Alzheimer’s. Source: Thinkstock Images

Scientists are beginning a major study to see if an experimental drug can protect healthy seniors whose brains harbor silent signs that they are at risk of Alzheimer’s disease.

It is one of the most ambitious attempts yet to thwart Alzheimer’s.

Researchers expect to screen thousands of volunteers ages 65 to 85, hunting those whose brain scans show they have a sticky build-up believed to play a key role in development of Alzheimer’s.

That does not guarantee someone will get sick. But the study will test if early use of a drug designed to target the gunk makes a difference for those who do.

Whether the drug works or not, researchers say the unique study should give new insight into Alzheimer’s risks and how people cope with the knowledge.


📣 For more lifestyle news, click here to join our WhatsApp Channel and also follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement